Morgan, E E <br/><br/>
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.  [electronic resource] 

 -  Journal of neurovirology  Apr 2013 
 - 150-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-2443 
<br/><br/><label>Standard No.: </label>10.1007/s13365-013-0152-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Dementia Complex--blood<br/>Adult<br/>Age Factors<br/>Anti-Retroviral Agents--therapeutic use<br/>Antiretroviral Therapy, Highly Active<br/>Apolipoprotein E4--blood<br/>Asymptomatic Diseases<br/>CD4 Lymphocyte Count<br/>Cross-Sectional Studies<br/>Female<br/>Gene Dosage<br/>Genotype<br/>Humans<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Neuropsychological Tests<br/>Risk Factors<br/>Severity of Illness Index